Catalase Activity is Critical for Proteus mirabilis Biofilm Development, Extracellular Polymeric Substance Composition, and Dissemination during Catheter-Associated Urinary Tract Infection

Infect Immun. 2021 Sep 16;89(10):e0017721. doi: 10.1128/IAI.00177-21. Epub 2021 Jul 19.

Abstract

Proteus mirabilis is a leading uropathogen of catheter-associated urinary tract infections (CAUTIs), which are among the most common health care-associated infections worldwide. A key factor that contributes to P. mirabilis pathogenesis and persistence during CAUTI is the formation of catheter biofilms, which provide increased resistance to antibiotic treatment and host defense mechanisms. Another factor that is important for bacterial persistence during CAUTI is the ability to resist reactive oxygen species (ROS), such as through the action of the catalase enzyme. Potent catalase activity is one of the defining biochemical characteristics of P. mirabilis, and the single catalase (katA) gene in strain HI4320 was recently identified as a candidate fitness factor for UTI, CAUTI, and bacteremia. Here, we show that disruption of katA results in increased ROS levels, increased sensitivity to peroxide, and decreased biofilm biomass. The biomass defect was due to a decrease in the production of extracellular polymeric substances (EPS) by the ΔkatA mutant and specifically due to reduced carbohydrate content. Importantly, the biofilm defect resulted in decreased antibiotic resistance in vitro and a colonization defect during experimental CAUTI. The ΔkatA mutant also exhibited decreased fitness in a bacteremia model, supporting a dual role for catalase in P. mirabilis biofilm development and immune evasion.

Keywords: CAUTI; EPS; Proteus mirabilis; bacteremia; biofilms; catalase; catheter; hydrogen peroxide.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Bacteremia / drug therapy
  • Bacteremia / microbiology
  • Biofilms / drug effects
  • Biofilms / growth & development*
  • Catalase / metabolism*
  • Catheter-Related Infections / drug therapy
  • Catheter-Related Infections / microbiology*
  • Catheters / microbiology
  • Coinfection / drug therapy
  • Coinfection / microbiology
  • Extracellular Polymeric Substance Matrix / metabolism*
  • Female
  • Humans
  • Mice
  • Mice, Inbred CBA
  • Proteus Infections / drug therapy
  • Proteus Infections / microbiology*
  • Proteus mirabilis / drug effects
  • Proteus mirabilis / enzymology*
  • Urinary Tract Infections / drug therapy
  • Urinary Tract Infections / microbiology*

Substances

  • Anti-Bacterial Agents
  • Catalase